Literature DB >> 910798

Age-specific correlation analysis of longitudinal blood pressure data.

B Rosner, C H Hennekens, E H Kass, W E Miall.   

Abstract

To evaluate the predictive value of blood pressures for future levels, longitudinal measurements were analyzed among Welsh subjects from age 5 to 74 at entry. The measurements were taken on 863 individuals from the Vale of Glamorgan in 1956, 1960, 1964, and 1971 and on 734 individuals from the Rhondda Fach in 1954, 1958, 1964, and 1971. The tracking correlation, defined as the correlation between blood pressure readings on the same person taken at two different times, is used as a descriptive measure of the magnitude of the association. The tracking correlations range from 0.25 to 0.6-0.7 with most of the increases occurring before age 20. The tracking correlation depends on initial age, sex, and time interval between measurements. The age-specific tracking correlations decrease as time interval between measurements increases. For a given time interval, the age-specific correlations are slightly higher for females than for males. These findings are very similar for each of the two regions studied.

Entities:  

Mesh:

Year:  1977        PMID: 910798     DOI: 10.1093/oxfordjournals.aje.a112466

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  37 in total

1.  Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study.

Authors:  Jason H Y Wu; Rozenn N Lemaitre; Irena B King; Xiaoling Song; Frank M Sacks; Eric B Rimm; Susan R Heckbert; David S Siscovick; Dariush Mozaffarian
Journal:  Circulation       Date:  2012-01-26       Impact factor: 29.690

2.  Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies.

Authors:  Joanne Kotsopoulos; Shelley S Tworoger; Hannia Campos; Fung-Lung Chung; Charles V Clevenger; Adrian A Franke; Christos S Mantzoros; Vincent Ricchiuti; Walter C Willett; Susan E Hankinson; A Heather Eliassen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-23       Impact factor: 4.254

Review 3.  Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis.

Authors:  Xiaoli Chen; Youfa Wang
Journal:  Circulation       Date:  2008-06-16       Impact factor: 29.690

4.  Circulating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study.

Authors:  Dariush Mozaffarian; Rozenn N Lemaitre; Irena B King; Xiaoling Song; Donna Spiegelman; Frank M Sacks; Eric B Rimm; David S Siscovick
Journal:  Ann Intern Med       Date:  2011-08-02       Impact factor: 25.391

5.  Consistency of microvascular and autonomic abnormalities in diabetes.

Authors:  F H Karachaliou; K Karavanaki; R Greenwood; H Morgan; J D Baum
Journal:  Arch Dis Child       Date:  1996-08       Impact factor: 3.791

6.  Ambulatory monitoring of blood pressure should be restricted to scientific research.

Authors:  M Brueren
Journal:  BMJ       Date:  1996-11-23

7.  Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II.

Authors:  Rebecca E Graff; Eunyoung Cho; Sara Lindström; Peter Kraft; Walter C Willett; A Heather Eliassen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-01-17       Impact factor: 4.254

8.  Arachidonic acid metabolites, hypertension and arteriosclerosis.

Authors:  P C Weber; W Siess; B Scherer; E Held; H Witzgall; R Lorenz
Journal:  Klin Wochenschr       Date:  1982-05-17

9.  Blood pressure in infants children and adolescents.

Authors:  A J Moss
Journal:  West J Med       Date:  1981-04

10.  Circulating 2-hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women.

Authors:  A Heather Eliassen; Stacey A Missmer; Shelley S Tworoger; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.